The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. FibroGen Inc shares valued at $50,663 were purchased by Wettig Thane on Mar 24 ’25. At $0.35 per share, Wettig Thane acquired 145,000 shares. The insider’s holdings grew to 543,329 shares worth approximately $2.8 million following the completion of this transaction.
Also, Schoeneck James A purchased 250,000 shares, netting a total of over 88,000 in proceeds. Following the buying of shares at $0.35 each, the insider now holds 323,722 shares.
Before that, Schoeneck James A had added 50,000 shares to its account. In a trade valued at $17,040, the Director bought FibroGen Inc shares for $0.34 each. Upon closing the transaction, the insider’s holdings increased to 50,000 shares, worth approximately $1.93 million.
As published in a research note from BofA Securities on August 08, 2023, FibroGen Inc [FGEN] has been rated down from a Neutral to an Underperform and the price target has been revised to $2 from $4. Analysts at William Blair downgraded the stock from ‘”an Outperform”‘ to ‘”a Mkt perform”‘ outlook in a report released in late June. As of June 26, 2023, Stifel has decreased its “Buy” rating to a “Hold” for FGEN. Earlier on June 26, 2023, Raymond James downgraded its rating. Their new recommendation was “a Mkt perform” for FGEN stock which previously was a “an Outperform”.
Analyzing FGEN Stock Performance
On last trading session,, FibroGen Inc [NASDAQ: FGEN] plunged -12.24% to $5.16. The stock’s lowest price that day was $5.16, but it reached a high of $6.0199 in the same session. During the last five days, there has been a drop of approximately -33.20%. Over the course of the year, FibroGen Inc shares have dropped approximately -61.02%. Shares of the company reached a 52-week high of $21.94 on 02/20/25 and a 52-week low of $5.16 on 06/18/25.
Support And Resistance Levels for FibroGen Inc (FGEN)
According to the 24-hour chart, there is a support level at 4.87, which, if violated, would cause prices to drop to 4.59. In the upper region, resistance lies at 5.73. The next price resistance is at 6.31. RSI (Relative Strength Index) is 23.08 on the 14-day chart, showing oversold technical sentiment.
Is FibroGen Inc subject to short interest?
Stocks of FibroGen Inc saw a sharp steep in short interest on 2025-05-30 dropping by 1797.0 shares to 0.15 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 0.15 million shares. A decline of -1.21% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.22 of the overall float, the days-to-cover ratio (short ratio) decline to 5.22.
Which companies own the most shares of FibroGen Inc (FGEN)?
In terms of FibroGen Inc share price expectations, FactSet research, analysts set an average price target of 28 in the next 12 months, up nearly 376.19% from the previous closing price of $5.88. Analysts anticipate FibroGen Inc stock to reach 28 by 2025, with the lowest price target being 28. In spite of this, 2 analysts ranked FibroGen Inc stock as Buy at the end of 2025.
